UK Markets open in 21 mins

Allied Healthcare Products, Inc. (AHPI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
5.52-0.74 (-11.82%)
At close: 04:00PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) -5.10
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 316.41
52-week low 33.45
50-day moving average 35.88
200-day moving average 35.82

Share statistics

Avg vol (3-month) 31.54M
Avg vol (10-day) 37.65M
Shares outstanding 54.01M
Implied shares outstanding 6N/A
Float 83.19M
% held by insiders 126.96%
% held by institutions 14.79%
Shares short (14 Oct 2021) 486.24k
Short ratio (14 Oct 2021) 40.14
Short % of float (14 Oct 2021) 42.33%
Short % of shares outstanding (14 Oct 2021) 42.15%
Shares short (prior month 14 Sept 2021) 482.91k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 306 Dec 2016
Ex-dividend date 425 Jun 1996
Last split factor 21:2
Last split date 306 Dec 2016

Financial highlights

Fiscal year

Fiscal year ends 29 Jun 2021
Most-recent quarter (mrq)29 Jun 2021


Profit margin 4.65%
Operating margin (ttm)-1.45%

Management effectiveness

Return on assets (ttm)-1.76%
Return on equity (ttm)17.34%

Income statement

Revenue (ttm)36.28M
Revenue per share (ttm)9.04
Quarterly revenue growth (yoy)-17.50%
Gross profit (ttm)7.11M
EBITDA 52.65k
Net income avi to common (ttm)1.69M
Diluted EPS (ttm)-0.10
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)726.22k
Total cash per share (mrq)0.18
Total debt (mrq)2.09M
Total debt/equity (mrq)19.76
Current ratio (mrq)1.88
Book value per share (mrq)2.25

Cash flow statement

Operating cash flow (ttm)-3.78M
Levered free cash flow (ttm)-3.21M